Description
The National, Heart, Lung, and Blood Institute (NHLBI) convened a Working Group on September 13-14, 2012 in Bethesda, MD to discuss the current knowledge and future research needs of hormone-induced thrombosis in women. The aim of the meeting was to improve our understanding of the mechanisms that affect the thrombotic challenges unique to women throughout their lifespan. The objectives of the Working Group were to:
- Review the current state of knowledge of hormone-induced thrombosis in women and identify critical gaps in research and clinical areas
- Identify risk factors for hormone-induced thrombosis throughout the female reproductive and postmenopausal life cycle
- Prioritize research and clinical goals in this field
- Identify how NHLBI could facilitate research and advance our understanding of hormone-induced thrombosis in women.
The working group consisted of basic and clinical scientists, epidemiologists, and physicians with expertise in coagulation science, hematology, epidemiology, and obstetrics & gynecology including reproductive endocrinology, and maternal-fetal medicine. Representatives from the Women's Health Initiative in the NHLBI's Division of Cardiovascular Sciences (DCVS), the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), Department of Health and Human Services (DHHS), the Centers for Disease Control and Prevention (CDC), and the Food and Drug Administration (FDA) participated in the discussion. Dr. Janine Austin Clayton, Director of the NIH Office of Research on Women's Health addressed the group and summarized the NIH strategic plan for advancing women's health research (http://orwh.od.nih.gov/research/strategicplan/index.asp).